FOXE1 is a target for aberrant methylation in cutaneous squamous cell carcinoma

British Journal of Dermatology

Volumn 162, Issue 5, 2010, Pages 1093-1097

  Venza, I ^a   Visalli, M ^a   Tripodo, B ^a   De Grazia, G ^a   Loddo, S ^a   Teti, D ^a   Venza, M ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Cutaneous squamous cell carcinoma; FOXE1 gene; Gene expression; Promoter hypermethylation

Indexed keywords

DNA; FORKHEAD BOX E1 PROTEIN; FORKHEAD TRANSCRIPTION FACTOR; MESSENGER RNA; PROTEIN FOXE1; RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER TISSUE; CHROMOSOME 2Q; CONTROLLED STUDY; DNA EXTRACTION; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; SKIN CARCINOGENESIS; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; AZACITIDINE; CARCINOMA, SQUAMOUS CELL; DNA METHYLATION; DNA, NEOPLASM; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; RNA, NEOPLASM; SKIN NEOPLASMS;

EID: 77951240348     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2009.09560.x     Document Type: Article

References (33)

1. Johnson TM, Rowe DE, Nelson BR, Swanson NA. Squamous cell carcinoma of the skin (excluding lip and oral mucosa). J Am Acad Dermatol 1992 26 : 467 484.
2. Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med 2001 29 : 975 983. (Pubitemid 32240317)
3. Holme SA, Malinovszky K, Roberts DL. Changing trends in non-melanoma skin cancer in South Wales, 1988-98. Br J Dermatol 2000 143 : 1224 1229. (Pubitemid 32052759)
4. Ramsay HM, Fryer AA, Hawley CM et al. Non-melanoma skin cancer risk in the Queensland renal transplant population. Br J Dermatol 2002 147 : 950 956. (Pubitemid 35365443)
5. Marks R. The epidemiology of non-melanoma skin cancer: who, why and what can we do about it. J Dermatol 1995 22 : 853 857. (Pubitemid 26010661)
6. Hacker SM, Flowers FP. Squamous cell carcinoma of the skin. Will heightened awareness of risk factors slow its increase? Postgrad Med 1993 93 : 115 121.
7. Nataraj AJ, Trent JC, Ananthaswamy HN. p53 gene mutations and photocarcinogenesis. Photochem Photobiol 1995 62 : 218 230.
8. Bolshakov S, Walker CM, Strom SS et al. p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas. Clin Cancer Res 2003 9 : 228 234. (Pubitemid 36109738)
9. Campbell C, Quinn AG, Ro YS et al. p53 mutations are common and early events that precede tumor invasion in squamous cell neoplasia of the skin. J Invest Dermatol 1993 100 : 746 749. (Pubitemid 23151232)
10. Li G, Tron V, Ho V. Induction of squamous cell carcinoma in p53-deficient mice after ultraviolet irradiation. J Invest Dermatol 1998 110 : 72 5. (Pubitemid 28086067)
11. Pierceall WE, Goldberg LH, Tainsky MA et al. Ras gene mutation and amplification in human non melanoma skin cancers. Mol Carcinog 1991 4 : 196 202.
12. Spencer JM, Kahn SM, Jiang W et al. Activated ras genes occur in human actinic keratoses, premalignant precursors to squamous cell carcinomas. Arch Dermatol 1995 131 : 796 800.
13. Lazarov M, Kubo Y, Cai T et al. CDK4 coexpression with Ras generates malignant human epidermal tumorigenesis. Nat Med 2002 8 : 1105 1114. (Pubitemid 35175965)
14. Quinn AG, Sikkink S, Rees JL. Delineation of two distinct deleted regions on chromosome 9 in human non-melanoma skin cancers. Genes Chromosomes Cancer 1994 11 : 222 223. (Pubitemid 24372146)
15. Saridaki Z, Liloglou T, Zafiropoulos A et al. Mutational analysis of CDKN2A genes in patients with squamous cell carcinoma of the skin. Br J Dermatol 2003 148 : 638 648. (Pubitemid 36629740)
16. Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res 2001 61 : 3225 3229. (Pubitemid 32695003)
17. Tyler LN, Ai L, Zuo C et al. Analysis of promoter hypermethylation of death-associated protein kinase and p16 tumor suppressor genes in actinic keratoses and squamous cell carcinomas of the skin. Mod Pathol 2003 16 : 660 664. (Pubitemid 36871498)
18. Chiles MC, Ai L, Zuo C et al. E-cadherin promoter hypermethylation in preneoplastic and neoplastic skin lesions. Mod Pathol 2003 16 : 1014 1018. (Pubitemid 37280817)
19. Brown VL, Harwood CA, Crook T et al. p16INK4a and p14ARF tumor suppressor genes are commonly inactivated in cutaneous squamous cell carcinoma. J Invest Dermatol 2004 122 : 1284 1292. (Pubitemid 38651105)
20. van Doorn R, Gruis NA, Willemze R et al. Aberrant DNA methylation in cutaneous malignancies. Semin Oncol 2005 32 : 479 487. (Pubitemid 41396425)
21. Katoh M, Katoh M. Human FOX gene family. Int J Oncol 2004 25 : 1495 1500.
22. Chadwick BP, Obermayr F, Frischauf AM. FKHL15, a new human member of the forkhead gene family located on chromosome 9q22. Genomics 1997 41 : 390 396. (Pubitemid 27194791)
23. Holmberg E, Rozell BL, Toftgård R. Differential allele loss on chromosome 9q22.3 in human non-melanoma skin cancer. Br J Cancer 1996 74 : 246 250. (Pubitemid 26254137)
24. Brancaccio A, Minichiello A, Grachtchouk M et al. Requirement of the forkhead gene Foxe1, a target of sonic hedgehog signaling, in hair follicle morphogenesis. Hum Mol Genet 2004 13 : 2595 2606. (Pubitemid 39485408)
25. Sato N, Fukushima N, Maitra A et al. Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays. Cancer Res 2003 63 : 3735 3742. (Pubitemid 36793060)
26. Brune K, Hong SM, Li A et al. Genetic and epigenetic alterations of familial pancreatic cancers. Cancer Epidemiol Biomarkers Prev 2008 17 : 3536 3542.
27. Matsubayashi H, Canto M, Sato N et al. DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease. Cancer Res 2006 66 : 1208 1217. (Pubitemid 43165992)
28. Weisenberger DJ, Trinh BN, Campan M et al. DNA methylation analysis by digital bisulfite genomic sequencing and digital MethyLight. Nucleic Acids Res 2008 36 : 4689 4698.
29. Sacks PG. Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck. Cancer Metastasis Rev 1996 15 : 27 51.
30. Venza M, Visalli M, Venza I et al. Altered binding of MYF-5 to FOXE1 promoter in non-syndromic and CHARGE-associated cleft palate. J Oral Pathol Med 2009 38 : 18 23.
31. Murao K, Kubo Y, Ohtani N et al. Epigenetic abnormalities in cutaneous squamous cell carcinomas: frequent inactivation of the RB1/p16 and p53 pathways. Br J Dermatol 2006 155 : 999 1005. (Pubitemid 44564511)
32. Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007 128 : 683 692.
33. Laird PW. Cancer epigenetics. Hum Mol Genet 2005 14 : R65 76.